Eosinophil peroxidase

Left:

Active site of eosinophil peroxidase in the resting (reduced) state. Pictured: Proximal histidine-asparagine interaction (bottom); distal histidine and bound water (top). In the oxidized form, the oxyferryl radical takes the place of the bound solvent molecule, and the halide substrate binds alongside that. Not pictured: other bound solvent water molecules. Refer to PDB crystal structures or refs. and.

Eosinophil peroxidase (EPO) is a heme-containing enzyme that is a major component of the large granules found in eosinophils, a type of white blood cells. Eosinophils are primarily involved in the body's immune response to parasitic infections and are also implicated in the pathogenesis of various allergic reactions and asthma. EPO plays a critical role in the immune defense mechanism through the production of reactive oxygen species and the generation of halogenating agents, which are toxic to pathogens.

Structure and Function

Eosinophil peroxidase is a member of the peroxidase-cyclooxygenase superfamily. It is similar in structure to myeloperoxidase (MPO), which is found in neutrophils, another type of white blood cell. However, EPO has unique structural features and enzymatic activities that distinguish it from MPO. EPO catalyzes the reaction of hydrogen peroxide with chloride and bromide ions to produce hypochlorous acid and hypobromous acid, respectively. These reactive compounds are potent antimicrobials that can kill a wide range of pathogens, including bacteria, viruses, and parasites.

Role in Disease

While EPO is essential for the immune response to pathogens, its activity must be tightly regulated. Excessive or misplaced action of EPO can contribute to tissue damage and inflammation, playing a role in the development of diseases such as asthma, eosinophilic esophagitis, and other eosinophil-related disorders. In asthma, for example, the release of EPO and other eosinophilic granule proteins can damage the airway tissue and exacerbate the inflammatory response.

Clinical Significance

The measurement of EPO levels in biological fluids can serve as a marker for eosinophil activation and has potential diagnostic value in diseases characterized by eosinophilic inflammation. Additionally, targeting EPO or its pathways has been explored as a therapeutic strategy to mitigate the detrimental effects of eosinophilic inflammation in allergic diseases and asthma.

Research Directions

Research on eosinophil peroxidase continues to explore its exact mechanisms of action, its role in disease, and potential therapeutic interventions. Understanding the balance between its protective roles in immunity and its contributions to pathology is crucial for developing targeted therapies that can mitigate eosinophilic inflammation without compromising immune defense.

‎